NCT07152821
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07152821
Title Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma (BATTMAN)
Acronym BATTMAN
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Canadian Cancer Trials Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
BCCA - Prince George Prince George British Columbia V2M 7E9 Canada Details
BCCA - Vancouver Vancouver British Columbia V5Z 4E6 Canada Details
Lakeridge Health Oshawa Oshawa Ontario L1G 2B9 Canada Details
North York General Hospital Toronto Ontario M2K 1E1 Canada Details
Sinai Health System Toronto Ontario M5G 1X5 Canada Details
University Health Network Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field